Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 May 2018

The National Research Foundation (NRF) ratings are considered the benchmark for research excellence. This year the University of the Free State (UFS) has 17 newly NRF-rated researchers. This brings the total number of NRF-rated researchers at UFS to 160.
 
NRF ratings are allocated based on a researcher’s recent research outputs and impact as perceived by national and international peer reviewers. The rating system encourages researchers to publish high-quality research papers in journals of high impact and to publish books through reputed academic publishers. The NRF rating system is a valuable tool for benchmarking the quality of our researchers against the best in the world.

Research at the heart of the UFS
Prof Francis Petersen, Rector and Vice-Chancellor, has indicated that the UFS provides significant support to researchers to apply for new NRF ratings or to re-apply for rating. These initiatives include the mock NRF rating panels managed by the Prestige Scholars Programme (PSP), evaluation of individual research outputs and recommendations on timely applying for rating, and improvements on rating applications by a panel consisting of internal and external members. These initiatives are bearing fruit by increasing the number of rated researchers who will transform the research profile and increase the diversity of UFS researchers.
Cultivating the best researchers.

According to Eleanor van der Westhuizen, from Research Development: “The rating of individuals is based primarily on the quality and impact of their research outputs over the past eight years, taking into consideration the evaluation made by local and international peers. It identifies researchers who count among the leaders in their fields of expertise and gives recognition to those who have a sustained production of high-quality research outputs. Several South African universities use the outcomes of the NRF evaluation and rating process to position themselves as research-intensive institutions, while others such as the UFS provide incentives for their staff members to acquire and maintain a rating.”

Cream of the crop
The UFS has also upped the ante with regard to its total number of NRF-rated researchers during the latest rating and evaluation, with an increase from 149 to 160 rated researchers in 2018.
 
Prof Heidi Hudson, Dean of Humanities, received an NRF B-rating, which brings the total of B-rated researchers to six. Other B-rated researchers incude Prof Johann Meyer (Mathematics), Prof Fanie Snyman and Prof Francois Tolmie (Theology), Prof Felicity Burt (Medical Microbiology) and Prof Andre Roodt (Chemistry). A total number of 10 new C-ratings and six new Y-ratings were achieved during the 2018 evaluation process.

“NRF-rating is indicative of the university’s drive to enhance its research profile nationally and internationally. Congratulations to all the scientists and scholars who received a rating in 2017. I am thankful to our academics for their commitment to the rating process,” said Prof Corli Witthuhn, Vice-Rector: Research at the UFS.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept